Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) ...

Russia becomes the first country to deploy a cancer vaccine, launching trials within months. Using cutting-edge mRNA technology, the treatment is personalised to target a patient’s tumour. With ...

Replimune stock falls as FDA denies skin cancer drug approval and investors sue over alleged misstatements tied to the IGNYTE ...

The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

Bird flu, for the moment, appears to be under control. But experts have a warning for federal and state health officials.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Biotech company Amgen (NASDAQ:AMGN) will be reporting results this Tuesday after market hours. Here’s what to look for.

The company reported a net loss of $825 million for the quarter. Additionally, Moderna announced a $300 million reduction at the high end of their 2025 projected revenue range due to a timing shift of ...

A strategy of selecting stocks based on rapid revenue growth has outperformed the broad market over the decades.

Despite gold’s rebound, silver drops on soft China data and trade fears. Explore the full silver analysis and what it means ...